De novo variants cause complex symptoms in HSP- ATL1 (SPG3A) and uncover genotype–phenotype correlations
Human Molecular Genetics · 2023
DOI: 10.1093/hmg/ddac182 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2023. Verfasst von Julian E Alecu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Spastic Paraplegia, Hereditary. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NICHD NIH HHS, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Pathogenic variants in ATL1 are a known cause of autosomal-dominantly inherited hereditary spastic paraplegia (HSP-ATL1, SPG3A) with a predominantly ‘pure’ HSP phenotype. Although a relatively large number of patients have been reported, no genotype–phenotype correlations have been established for specific ATL1 variants. Confronted with five children carrying de novo ATL1 variants showing early, complex and severe symptoms, we systematically investigated the molecular and phenotypic spectrum of HSP-ATL1. Through a cross-sectional analysis of 537 published and novel cases, we delineate a distinct phenotype observed in patients with de novo variants. Guided by this systematic phenotyping approach and structural modelling of disease-associated variants in atlastin-1, we demonstrate that this distinct phenotypic signature is also prevalent in a subgroup of patients with inherited ATL1 variants and is largely explained by variant localization within a three-dimensional mutational cluster. Establishing genotype–phenotype correlations, we find that symptoms that extend well beyond the typical pure HSP phenotype (i.e. neurodevelopmental abnormalities, upper limb spasticity, bulbar symptoms, peripheral neuropathy and brain imaging abnormalities) are prevalent in patients with variants located within this mutational cluster.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
- Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, 91054, Germany.
- Movement Disorders Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
- Movement Disorders Program, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
- Intellectual and Developmental Disabilities Research Center, Boston Children's Hospital, Boston, MA 02115, USA.
- The Manton Center for Orphan Disease Research, Boston Children's Hospital, Boston, MA 02115, USA.
ORCID-Profile: Julian E Alecu, Siddharth Srivastava, Craig Blackstone, Darius Ebrahimi-Fakhari
Förderung
- NINDS NIH HHS
- NICHD NIH HHS
- Deutsche Forschungsgemeinschaft
- German Academic Exchange Service
- German National Academic Foundation
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Alecu, J. E., Saffari, A., Jordan, C., Srivastava, S., Blackstone, C., & Ebrahimi-Fakhari, D. (2023). De novo variants cause complex symptoms in HSP- ATL1 (SPG3A) and uncover genotype–phenotype correlations. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddac182
Vancouver
Alecu JE, Saffari A, Jordan C, Srivastava S, Blackstone C, Ebrahimi-Fakhari D. De novo variants cause complex symptoms in HSP- ATL1 (SPG3A) and uncover genotype–phenotype correlations. Human Molecular Genetics. 2023. doi:10.1093/hmg/ddac182
BibTeX
@article{Alecu2023,
author = {Alecu, Julian E and Saffari, Afshin and Jordan, Catherine and Srivastava, Siddharth and Blackstone, Craig and Ebrahimi-Fakhari, Darius},
title = {De novo variants cause complex symptoms in HSP- ATL1 (SPG3A) and uncover genotype–phenotype correlations},
journal = {Human Molecular Genetics},
year = {2023},
doi = {10.1093/hmg/ddac182}
}
EUVIMED